home / stock / eltp / eltp news


ELTP News and Press, Elite Pharmaceuticals Inc. From 06/15/21

Stock Information

Company Name: Elite Pharmaceuticals Inc.
Stock Symbol: ELTP
Market: OTC
Website: elitepharma.com

Menu

ELTP ELTP Quote ELTP Short ELTP News ELTP Articles ELTP Message Board
Get ELTP Alerts

News, Short Squeeze, Breakout and More Instantly...

ELTP - Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2021 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q4 2021 Earnings Conference Call June 15, 2021, 11:30 AM ET Company Participants Nasrat Hakim - Chairman and CEO Marc Bregman - Chief Financial Officer Conference Call Participants Presentation Operator Good morning, ladies and gentlemen. And welcome to the ...

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information

Conference Call Scheduled for Tuesday, June 15 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 14, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company')(OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year end...

ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021

Financials for Fiscal Year Ended March 31, 2021 will be released June 14, 2021 NORTHVALE, NJ / ACCESSWIRE / June 8, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the "Company') (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that it w...

ELTP - Elite Pharmaceuticals enters exclusive distribution agreement with Prasco

Elite Pharmaceuticals ([[ELTP]] -3.5%) enters a license, supply, and distribution agreement with Prasco for Elite's Abbreviated New Drug Application for Loxapine Succinate capsules.Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed ...

ELTP - Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has launched Elite's generic Loxapine capsules. Elite entered a license, supply, and distributio...

ELTP - Elite Pharmaceuticals names Marc Bregman as chief financial officer

Elite Pharmaceuticals (ELTP) announces that Marc Bregman has been appointed as Chief Financial Officer, effective May 17, 2021.Bregman has more than 27 years of financial and operational experience, including positions as Controller at Langan Engineering & Environmental Ser...

ELTP - Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

NORTHVALE, NJ / ACCESSWIRE / April 29, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced today that Marc Bregman, CPA, has been appointed as Chief Financial Officer (CF...

ELTP - Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q3 2021 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q3 2021 Earnings Conference Call February 17, 2021 11:30 AM ET Company Participants Nasrat Hakim - President & Chief Executive Officer Carter Ward - Chief Financial Officer Conference Call Participants Presentation Operator Good morning, ladies and gentl...

ELTP - Elite Pharmaceuticals reports FQ3 results

Elite Pharmaceuticals (ELTP): FQ3 GAAP EPS of $0.00.Revenue of $6.05M (+19.6% Y/Y)10QPress Release For further details see: Elite Pharmaceuticals reports FQ3 results

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2021 Ended December 31, 2020 and Provides Conference Call Information

Conference Call Scheduled for Wednesday, February 17 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 16, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products, announced re...

Previous 10 Next 10